Hyperbaric Oxygenation Treatment and Quality of Life

CompletedOBSERVATIONAL
Enrollment

137

Participants

Timeline

Start Date

August 31, 2018

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Cancer
Interventions
OTHER

Hyperbaric oxygen treatment

"Participants in this study will receive hyperbaric oxygen treatment (HBOT) but the investigators do not assign this specific intervention to the study participants. Thus, the patients in this study will receive HBOT as part of routine medical care. Consequently, we regard this as an observational study because the patients will get HBOT independently of the study and they are NOT assigned prospectively to HBOT according to a protocol to evaluate the effects.~HBOT for pelvic radiation injury typically involves a treatment pressure of 2.4 ATA (Atmospheres Absolute) breathing oxygen for 90 minutes. The treatment is delivered as series treatment, usually daily treatment up to 30 dives."

Trial Locations (1)

5013

University of Bergen/Haukeland University Hospital, Bergen

All Listed Sponsors
collaborator

Haukeland University Hospital

OTHER

lead

University of Bergen

OTHER

NCT03570229 - Hyperbaric Oxygenation Treatment and Quality of Life | Biotech Hunter | Biotech Hunter